Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Institute consisting of an internationally recognized myeloma center, five full-time multiple myeloma clinicians, a robust bone marrow procurement operation, and a cellular therapy program. In addition
-
/Lymphoma Research to lead a research program . The Translational Scientist will provide scientific leadership for the program. Which will be located in a major growing and expanding clinical program within
-
NOVA Institute for Medical Systems Biology (NIMSB) announces Four Independent Group Leader positions
Center for Molecular Medicine (MDC) in Berlin, Germany, funded by the European Union through the Horizon Europe Teaming for Excellence programme. NIMSB strives to become an international leader in
-
Summary The Senior Science Program Coordinator supports key administrative functions for HHMI’s science programs, with a focus on programming and events for HHMI scientists. This role requires
-
generation of scientists with the skills and knowledge from multiple disciplines to become leaders in childhood hematological malignancy research. The program provides an enriched training experience
-
cutting-edge experimental approaches. Successful candidates are expected to establish an independent and internationally recognized research program and to contribute to the missions of the Division in
-
St. Jude Children's Research Hospital's recently established Office of Large Grant Development (OLGD) is seeking a dynamic and detail-oriented Research Program Manager. The OLGD supports St. Jude
-
background and field experience. The research of the successful candidate is not limited to a particular scale, although candidates should work across multiple scales. The successful candidate’s program
-
The Program Manager in Global Pediatric Medicine's Infectious Diseases team will be over capacity building, implementation science, quality improvement, and focus on research. The right candidate
-
The newly established Program for Memory Longevity (PML), led by Attila Losonczy, MD, PhD, in the O’Donnell Brain Institute (OBI) and the Department of Neuroscience at the University of Texas